Prostate Cancer - Results from #24000

Improving the communication of benefits and harms of treatment strategies: Decision AIDS for localized prostate cancer treatment decisions - Abstract January 26, 2013

Active surveillance: The Canadian experience with an "inclusive approach" - Abstract January 26, 2013

Quality of life in men undergoing active surveillance for localized prostate cancer - Abstract January 26, 2013

Detection rate of clinically insignificant prostate cancer increases with repeat prostate biopsies - Abstract January 26, 2013

Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer - Abstract January 26, 2013

Guideline-discordant androgen deprivation therapy in localized prostate cancer: Patterns of use in the medicare population and cost implications - Abstract January 25, 2013

Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer - Abstract January 25, 2013

Results from the Scandinavian Prostate Cancer Group Trial Number 4: A randomized controlled trial of radical prostatectomy versus watchful waiting - Abstract January 25, 2013

Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrence - Abstract January 25, 2013

Use of immunohistochemistry in routine workup of prostate needle biopsies - Abstract January 25, 2013

Real-time sonoelastography compared to magnetic resonance imaging using four different modalities at 3.0T in the detection of prostate cancer: Strength and weaknesses - Abstract January 25, 2013

Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: A prospective single cohort study - Abstract January 25, 2013

Personal epigentic "signatures" found consistent in prostate cancer patient metastases January 24, 2013

What is the risk posed by prostate cancer? - Abstract January 24, 2013

Active surveillance for prostate cancer: An underutilized opportunity for reducing harm - Abstract January 24, 2013

Overview of randomized controlled treatment trials for clinically localized prostate cancer: Implications for active surveillance and the United States Preventative Task Force report on screening - Abstract January 24, 2013

Temporal changes in the pathologic assessment of prostate cancer - Abstract January 24, 2013

Temporal changes in the clinical approach to diagnosing prostate cancer - Abstract January 24, 2013

The Prostate Cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): Design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically Loca January 24, 2013

Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer - Abstract January 24, 2013

Page 1201 of 1436